Abstract Most evidence for a key role of calcium entry in hypoxia-induced renal damage stems from studies with calcium channel blockers. In proximal tubules, a primary site of renal ischaemic injury, only phenylalkylamines, especially verapamil, have been studied. In the present study the effect of the dihydropyridine felodipine on hypoxic injury in isolated rat proximal tubules was investigated. To discriminate between the block of calcium entry and other effects, the enantiomers and a non-calcium blocking derivative of felodipine (H186/86) were included. Cell membrane injury was assessed by measuring the release of lactate dehydrogenase (LDH). At high concentrations (100 ~tM) felodipine, H 186/86 and the two enantiomers all protected rat proximal tubules against hypoxiainduced injury to the same extent. Absence of extracellular calcium did not offer protection, but rather enhanced hypoxic injury. All dihydropyridines used increased the intracellular potassium concentration during normoxia. Felodipine attenuated the hypoxiainduced loss of cellular potassium. We have tried to mimic the effects of felodipine by using potassium channel blockers. The potassium channel blockers quinidine and glibenclamide afforded some protection against hypoxic injury, although their effects on cellular potassium were equivocal. We conclude that the dihydropyridine calcium channel blocker felodipine protects rat proximal tubules against hypoxic injury via a calcium-independent mechanism. We propose that high levels of intracellular potassium and attenuation of potassium loss during hypoxia are important in this protection.
Introduction
The role of calcium in hypoxic renal injury is still a matter of dispute. Most evidence in favour of a role for calcium stems from experiments with calcium channel blockers (CCBs). Indeed, it has been demonstrated that CCBs afford protection in models of in vivo ischaemic renal injury [2, 4, 23, 25, 29] . However, protection in these models could be ascribed to the well-known vasodilatory and diuretic properties of CCBs [29] . To evaluate direct protective effects of CCBs on renal tubular epithelium, studies have been performed in in vitro models of ischaemic renal injury, using freshly isolated renal tubules or renal cell cultures. In these model systems CCBs of the phenylalkylamine class have been studied and proven effective. Verapamil protected isolated rat proximal tubules against hypoxia [30] and methoxyverapamil afforded partial protection against anoxic injury in rabbit proximal tubular cells [22] .
At present it is unknown whether CCBs of other classes are able to attenuate hypoxic cell injury. In addition, it has not been proven that phenylalkylamines exert their protective effects via inhibition of calcium influx. The concentration of verapamil needed to protect rat proximal tubules from hypoxic injury was relatively high (100 gM) and protection was independent of the presence of extracellular calcium [30] . CCBs could offer protection by a variety of mechanisms. They not only show vasodilatory properties [6] , but at high concentrations they also interact with sodium and potassium channels [3, 8, 9, 10, 20, 27] and some could act as antiperoxidants [13] .
We have studied the effects of the dihydropyridine felodipine on hypoxic injury in isolated rat proximal tubules. In order to discriminate between calcium entry inhibition and other effects of felodipine, a non-calcium blocking felodipine derivative and the felodipine stereoisomers were included in our study. Felodipine indeed protects rat proximal tubules against hypoxia-induced plasma membrane injury. Although this finding seems to support a role for calcium in hypoxia-induced injury, we present evidence that the protection by felodipine is not due to a blockade of calcium influx, but might be related to effects on potassium channels resulting in attenuation of potassium efflux during hypoxia.
Low-calcium experiments
In several experiments we have studied the effect of low-calcium medium on hypoxic injury. For these low-calcium experiments, we followed the standard procedure for isolation and purification of the tubules. After the initial period of warming, the proximal tubules were washed twice with nominally calcium-free buffer and subsequently resuspended in this same buffer (final calcium concentration approximately 10 gM) [22] . Control flasks were supplemented with 1 mM CaCle.
Stock solutions

Materials and methods
Isolation of rat proximal tubules
Proximal tubules were isolated from kidney cortex of male SpragueDawley rats weighing 200-300 g by collagenase digestion (Collagenase A, Boehringer Mannheim, Almere, The Netherlands) and centrifugation on a Percoll (Pharmacia, Woerden, The Netherlands) gradient as described by Wetzels et al. [30] . Between the period of incubation in collagenase and the centrifugation step, cortex tissue was suspended in buffer supplemented with 1% albumin (Albumin Fraction V fatty acid free, Boehringer Mannheim) for approximately 15 rain. Purified tubules were suspended in a modified Krebs-Henseleit buffer of pH 7.3, gassed with 95%OJ5%CO> containing (in raM): D-glucose 5; MgSO4 1; NaCt 106; NaHCO3 20; KC1 5; NaH2PO4 2; 4-(2-hydroxyethyl)-l-piperazineethanesulphonic acid (HEPES) 10; CaC12 1; L-glutamine 2; nbutyric acid 10; L-lactic acid 4. The suspension, containing typically 1.5-3.0 mg protein/ml, was gassed with 95%Od5%CO2 for 5 min on ice and then warmed up gradually (110 rain at room temperature, 10 min at 37 ~ C). Aliquots of 5 7 ml were put in siliconized (Sigmacote, Sigma. Axel, The Netherlands) Erlenmeyer flasks (25 ml) and protective compounds or the appropriate vehicles were added. The experiment was started by gassing individual flasks with either 95%OJ5%CO2 (normoxia) or 95%N2/5%CO2 (hypoxia) in a shaking waterbath at 37 ~ C. After 5 min, the flasks were sealed.
Potassium and lactate dehydrogenase assays
Samples for the assessment of cell membrane injury and for the determination of intracellular potassium contents were taken after 15 and 30 min of incubation. Cell membrane injury was assessed by release of lactate dehydrogenase (LDH) [30] . Increased release of LDH indicates complete loss of cell membrane integrity, and reflects irreversible injury. LDH activity in the supernatant was expressed as a percentage of total LDH activity. To determine intracellular potassium levels, samples were centrifuged through 700 btl of L-bromododecane (Aldrich, Axel, The Netherlands) into 200 btl of sucrose/Ficoll (270 mM sucrose, 4% Ficoll 400, Pharmacia, Woerden, The Netherlands) and further processed for atomic absorption spectroscopy [30] . Potassium concentrations are expressed in nmoles per milligram protein. Protein was quantified by the method developed by Lowry et al. [16] . When using this methodology for the measurement of intracellular potassium, it must be remembered that severely damaged tubules do not pass through the oil layer. Therefore, injury is reflected by a low recovery of protein in the sucrose/Ficoll pellet. After 30 rain of hypoxic incubation, hardly any protein passes through the oil into the sucrose/Ficoll layer. When the amount of protein recovered in the pellet is low (i.e. < 0.2 mg/ml), the results of the potassium measurements are no longer reliable.
Concentrated stock solutions (100 mM) of felodipine (Astra Hfissle, M61ndal, Sweden), its non-calcium blocking derivative H186/86 (Astra Hfissle) and the felodipine isomers (Astra H~issle) were stored maximally for 1 month at room temperature and shielded from light. Stock solutions were prepared in PEG400 according to the instructions of the Astra company. Final concentrations of PEG400 were routinely 0.1% v/v and never exceeded 1% v/v. All vehicles were tested for their influence on LDH release and intracellular potassium concentration. The potassium channel blockers were added from concentrated stocks: 100mM quinidine HC1 in PEG400, 1 M quinine sulphate (Fluka, Buchs, Switzerland) in a mixture of 2 parts chloroform and 1 part ethanol, 10 mM and 500 mM glibenclamide in dimethylsulphoxide (DMSO). Appropriate controls were routinely assayed.
Materials
All chemicals were of the purest grade and obtained from Sigma (Axel, The Netherlands) or Merck (Amsterdam, The Netherlands) unless otherwise indicated.
Statistical analysis
All reported data are expressed as means + SEM. Statistical analysis was performed using analysis of variance (ANOVA) and comparisons between groups were done using StudentNewman-Keuls tests rising the INSTAT software (Graphpad, San Diego, Calif., USA). A P value below 0.05 is considered significant.
Results
LDH release and intracellular potassium content during normoxia and hypoxia
In our preparation of isolated tubules, LDH release amounted to 14 + 3% after the initial period of warming (t = 0). During normoxic incubations LDH release increased further to 24 + 2% after 30 min. Hypoxic incubation of the tubules resulted in a marked increase in LDH release (Fig. 1) . Intracellular potassium levels remained stable during normoxic incubation but decreased during one which was hypoxic (Table 1) . After 30 min of hypoxia, measurements of intracellular potassium were no longer reliable, since only a small amount of tubules had survived. (Fig. 1) . A lower concentration of felodipine (10 btM) did not protect the tubules (LDH release 38 + 3% vs 44 +_ 3% and 68 + 2% vs 72 + 3% for hypoxic control vs in the presence of 10 btM felodipine after 15 and 30 min respectively). Under normoxic conditions 100 JaM felodipine caused some tubular damage as assessed by LDH release (Fig. 1) .
Effect of low extracellular calcium
Isolated proximal tubules were incubated in media devoid of added calcium and free calcium levels in these solutions were estimated to be approximately 10 btM [22] . Removal of extracellular calcium resulted in a decrease of intracellular potassium under normoxic conditions and was deleterious to renal tubules under hypoxic conditions (Table 1 ). The protective effect of felodipine was still observed in the absence of extracellular calcium (Table 1) . 46 + 5*** 102 _+ 9*** 45 + 6**** 77 + 8 7 + felodipiue *P < 0.001 compared to normoxia,**P < 0.01 compared to hypoxia, ***P < 0.05 compared to hypoxia/low Ca 2+, ****P < 0.001 compared to hypoxia/low Ca 2+ Data are given as means + SEM of at least 7 experiments. *P < 0.05, **P < 0.01 compared to the respective normoxic or hypoxic control values (F+) does not block L-type calcium channels. Both isomers afforded protection against hypoxia as assessed by LDH release (Fig. 3) .
The non-calcium blocking felodipine derivative H186/86 also decreased LDH release during hypoxia, although the effect was less pronounced than with felodipine and became more marked after 30 min of incubation (Fig. 2) . Since the commercially available felodipine is a racemic mixture of two stereoisomers, we also tested the individual compounds in the same experimental settings. Felodipine-(F-) is the pharmacologically active compound, whereas felodipine+ Effects of dihydropyridines on potassium levels
We observed a significant increase in intracellular potassium levels during normoxic incubation of the proximal tubules with either felodipine or its derivative (Fig. 4) . During hypoxia felodipine significantly preserved potassium levels after 15 rain of incubation (Fig. 5 ). Both stereoisomers were equally effective in increasing intracellular potassium levels (Fig. 5) . In contrast, the felodipine derivative H186/86 did not significantly preserve potassium levels during hypoxia (data not shown).
Effects of potassium channel blockers 
30
We studied the effects of the potassium channel blockers quinine (1 mM), quinidine (1 raM) and glibenclamide (10 gM and 500 gM) under normoxic and hypoxic conditions. Quinine and quinidine increased intracellular potassium levels under normoxic conditions, but did not prevent the loss of potassium during hypoxia (Table 2) . Quinidine but not quinine attenuated cellular injury, as reflected by the level of LDH release after 30 min (Table 2) . Both blockers increased cell injury after 15 min of normoxic incubation. The damaging effect of quinidine became more marked after 30min (Table 2) . Glibenclamide (500~tM) preserved cell membrane integrity, as assessed by LDH release during 30 min of hypoxia (Fig. 6 ). Intracellular potassium levels during hypoxia (Fig. 6 ) and decreased intracellular potassium levels (261 + 12 nmol/mg protein vs 179 + 33 nmol/mg protein for normoxic control vs in the presence of 500 gM glibenclamide after 30 min). A lower concentration of glibenclamide (10 gM) did not have an effect on normoxic or hypoxic LDH release or on potassium levels (data not shown).
Discussion
The role of intracellular calcium in hypoxia-induced renal damage is still a matter of debate. Most evidence in favour of a role for calcium is based upon experiments with CCBs. Specifically, CCBs of the phenylalkylamine class have been demonstrated to protect renal tissue against oxygen deprivation injury both in vivo [23, 29] and in vitro [1, 22, 24, 30] . Certainly, the protective efficacy of the phenylalkylamine verapamil provides only indirect and weak evidence for a role of calcium in hypoxic renal injury. The development of single cell fluorescence imaging techniques has allowed direct measurements of intracellular calcium concentrations. Recent studies have shown that intracellular calcium increases during hypoxia in freshly isolated rat proximal tubules [15] and in isolated rabbit proximal tubule cells [22] , and a relationship between the increase of intracellular calcium and the occurrence of cell injury was suggested [15] . Although these studies point to a role for calcium in hypoxic injury, they do not unequivocally demonstrate that verapamil protects renal tubular cells by blocking calcium influx. Some investigators suggest that protection is independent of the calcium blocking properties of the drugs [1, 30] . Indeed, it has been demonstrated that relatively high concentrations of verapamil (100 ~tM) are required for protection [1, 30] . It was also shown that verapamil was protective in the absence of extracellular calcium [30] . Our present study with dihydropyridines demonstrates clearly that felodipine also protects isolated rat proximal tubules against hypoxia-induced plasma membrane injury as assessed by LDH release. Our data are in close agreement with the reported effects of verapamil. Although this may suggest a role for calcium in oxygen deprivation injury, we present four lines of evidence that protection by felodipine is not due to a blockade of calcium influx.
First, felodipine only protects rat proximal tubules against hypoxia-induced injury at high concentrations (100 gM). Binding ofdihydropyridine-type CCBs to Ltype Ca a+ channels, as characterized in cardiac tissue [6] and in depolarized smooth muscle cells [31] , occurs, however, at nanomolar concentrations. Still, it is possible that calcium channels present in rat proximal tubules can only be blocked at high concentrations. Different concentrations of dihydropyridines are reported to block L-type calcium channels in cardiac tissue (nanomolar range) and skeletal muscle (micromolar range) [6] . Also, binding of dihydropyridines to their receptor depends on factors varying between tissues and experimental conditions, such as membrane potential and the state of the channel (resting or inactivated) [6, 11, 14, 31] . Recently, Matsunaga et al. [8] characterized electrophysiologically an L-type like calcium channel present in cultured renal distal convoluted tubules. This channel could be blocked by 10 gM nifedipine.
Secondly, we have demonstrated that felodipine, like verapamil, protects renal tubules against hypoxic injury in the absence of extracellular calcium. Lowering of the extracellular calcium concentration per se did not afford protection, but rather increased hypoxic injury. Although these results might suggest that calcium influx is not involved in the induction of hypoxic renal injury, they do not allow straightforward conclusions. The absence of calcium causes marked alterations in cell metabolism, as reflected by a decrease in intracellular potassium and adenosine 5'-triphosphate (ATP) [30] . These changes in cell metabolism could well be responsible for the increased cellular injury occurring under hypoxic conditions. Also, in view of the important role of calcium in the regulation of cell volume [19] , lowering of extracellular calcium could prevent cells from regulating their volume after swelling. Therefore, our data do not allow us to conclude what sort of damage is prevented by felodipine in low calcium media.
A third line of evidence is provided by the results of the experiments using the non-calcium blocking felodipine derivative H186/86. H186/86 is a dihydropyridine analogue which does not possess either calcium antagonistic or vasodilatory properties [5] . In our model, this analogue protected renal tubules against hypoxia-induced damage in the same concentration range as felodipine (100 ~tM but not 10 gM).
Finally, the effects of the individual enantiomers of felodipine were studied in our model. Normally, (--)-isomers have higher affinities for the target molecule than do (+)-isomers; for example, (-)-enantiomers of the dihydropyridines isradipine and nimodipine show a 10-to 100-fold higher affinity for L-type calcium channels than their (+)-counterparts [26] . Our experiments show that both stereoisomers of felodipine are equally effective in preventing disruption of tubular plasma membrane integrity and in increasing and preserving intracellular potassium levels. The protective pathway by which felodipine exerts its action is therefore not stereoselective.
Taken together, our data indicate that the CCB felodipine protects renal tubules from hypoxic injury independently of an effect on calcium entry.
Our data suggest a correlation between protection from hypoxic injury and the level ofintracellular potassium. When intracellular potassium decreased (in lowcalcium experiments), tubules became more vulnerable to hypoxic injury, whereas compounds that increased potassium levels (felodipine or its derivative) protected tubules from hypoxia. We tried to mimic the protective effect of felodipine by using the potassium channel blockers quinine, quinidine and glibenclamide. Both quinidine and glibenclamide protected hypoxic tubules against membrane injury~ as assessed by LDH leakage. This finding is in agreement with recent studies by Reeves and Shah [21] , who reported protection by tetraethylammonium and glibenclamide against hypoxiainduced injury in isolated proximal tubules of the rat.
Since felodipine and H186/86 protect rat proximal tubules against hypoxia and increase intracellular potassium levels, and some protection could be obtained by the use of the potassium channel blockers quinidine and glibenclamide, we propose that felodipine and its derivative exert their protective effect by blocking potassium channels, which would preserve intracellular potassium levels during the first period of hypoxia. Delaying cellular potassium leakage could slow sodium and chloride influx, and therefore cell swelling, which occurs during hypoxia when ATP is no longer available for the Na+-K+-ATPase. Tubules incubated in low-calcium media also exhibit an increased loss ofintracellular potassium. In this situation felodipine also prevented potassium loss, and attenuated cell injury. Interactions of CCBs with integral membrane proteins such as potassium and sodium channels are known to occur and have been described by several groups [3, 8, 9, 10, 20, 27] . The drug used in our experiments is very lipophilic and has a high lateral diffusion coefficient (as high as that for membrane lipids): 3.8 10 8 cm2.s-I [17] . Felodipine accumulates in membranes [17, 26] and is thought to bind to its receptor within the membrane bilayer, illustrating its hydrophobic character [17] . Therefore, both direct interactions with membrane proteins and indirect interactions via disruption of the lipid bilayer structure are likely to occur.
In our model ATP-sensitive potassium channels could be a target for felodipine. Actively transporting cells, such as renal epithelial cells, possess ATP-sensitive potassium channels to allow excessive intracellular potassium, pumped in by the Na+-K+-ATPases, to leave the cell again [12, 21, 28] . This prevents potassium accumulation and maintains a large electrical gradient for sodium entry across the apical membrane [12] . ATP-sensitive potassium channels open when ATP concentrations drop below 1 mM [7, 21] . Reeves and Shah [21] recently showed that hypoxia-induced potassium leakage is not due to a decreased influx caused by the cessation of the Na+-K+-pump, but to an increased potassium efflux. This efflux could be blocked by tetraethylammonium and glibenclamide (a specific ATP-sensitive potassium channel blocker) at concentrations known to block ATP-sensitive potassium channels in rabbit proximal tubules (inhibitory constant, Ki ~ 250 gM) [21, 28] . Thus, a blockade of ATPsensitive potassium channels during hypoxia, when ATP is depleted within minutes, would lead to preservation of intracellular potassium levels. In our model, felodipine and its stereoisomers preserved potassium levels during the first 15 min of hypoxia and provided almost complete protection. The specific blocker of ATP-sensitive potassium channels glibenclamide provided substantial protection in our experiments in the same concentrations as used by Reeves and Shah [21] . These results suggest a role for potassium channels in hypoxic tubular injury, and might explain the protective effect of substances which are capable of interacting with these channels. However, the evidence that blockade of potassium efftux is involved in the protection of cells against hypoxic injury is rather indirect. Most agents caused definite membrane injury when used at normoxic conditions, and increased potassium efftux. During hypoxia, both damaging and protective effects are operative, and the resulting LDH release and potassium levels can not be predicted easily. Further studies should focus on changes in potassium levels in individual tubular cells in relation to cell injury.
In summary, we have shown that felodipine protects isolated rat proximal tubules from hypoxia-induced injury in a calcium-independent way. Felodipine increased potassium levels during both normoxia and hypoxia. This latter finding suggests that felodipine and its derivative might afford protection against hypoxic injury by blocking potassium efftux. We have tried to corroborate further the relationship between hypoxic cell injury and cellular potassium efftux by studying the effects of the potassium channel blockers quinine, quinidine and glibenclamide. Only quinidine and especially glibenclamide afforded some protection against hypoxia-induced membrane injury, and the effects of these drugs on intracellular potassium levels were not conclusive. The interpretation of the effects of the potassium channel blockers is further hampered by the deleterious effects of these blockers on proximal tubules at normoxic conditions. We have also shown that both stereoisomers of felodipine are equally effective in reducing LDH leakage in our model. Since the (+)-isomer lacks vasodilatory and hence hypotensive properties, further study might reveal better and more effective ways to use this isoform of felodipine in patients at risk of hypoxic injury of the kidney and most likely other organs.
